| [1] |
|
| [2] |
Pilch J, Mizera J, Wiśnicki K, et al. Native renal arteries denervation as a therapy of refractory hypertension in patient after heart and kidney transplantation-5 years of observation[J]. J Clin Med, 2023, 12(17): 5458. DOI: 10.3390/jcm12175458.
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
Filippone EJ, Naccarelli GV, Foy AJ. Controversies in hypertension V: resistant and refractory hypertension[J]. Am J Med, 2024, 137(1): 12-22. DOI: 10.1016/j.amjmed.2023.09.015.
|
| [8] |
Matanes F, Khan MB, Siddiqui M, et al. An update on refractory hypertension[J]. Curr Hypertens Rep, 2022, 24(7): 225-234. DOI: 10.1007/s11906-022-01185-6.
|
| [9] |
|
| [10] |
|
| [11] |
Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[J]. Lancet, 2009, 373(9671): 1275-1281. DOI: 10.1016/S0140-6736(09)60566-3.
|
| [12] |
|
| [13] |
Sakakura K, Ladich E, Cheng Q, et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man[J]. J Am Coll Cardiol, 2014, 64(7): 635-643. DOI: 10.1016/j.jacc.2014.03.059.
|
| [14] |
|
| [15] |
|
| [16] |
Shao C, Zhou Y, You T, et al. Laparoscopic based renal denervation in a canine neurogenic hypertension model[J]. BMC Cardiovasc Disord, 2020, 20(1): 285. DOI: 10.1186/s12872-020-01546-6.
|
| [17] |
|
| [18] |
|
| [19] |
Sharp ASP, Kandzari DE, Townsend RR, et al. A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study[J]. Cardiovasc Revascularization Med, 2024, 68: 30-36. DOI: 10.1016/j.carrev.2024.04.005.
|
| [20] |
Liu Y, Zhu B, Zhu L, et al. Clinical outcomes of laparoscopic-based renal denervation plus adrenalectomy vs adrenalectomy alone for treating resistant hypertension caused by unilateral aldosterone-producing adenoma[J]. J Clin Hypertens (Greenwich), 2020, 22(9): 1606-1615. DOI: 10.1111/jch.13963.
|
| [21] |
|
| [22] |
Grimson KS, Bouckaert JJ, Heymans C. Production of a sustained neurogenic hypertension of renal origin[J]. Exp Biol Med, 1939, 42(1): 225-226. DOI: 10.3181/00379727-42-10856p.
|
| [23] |
Roubsanthisuk W, Kunanon S, Chattranukulchai P, et al. 2022 Renal denervation therapy for the treatment of hypertension: a statement from the Thai Hypertension Society[J]. Hypertens Res, 2023, 46(4): 898-912. DOI: 10.1038/s41440-022-01133-6.
|
| [24] |
Schmieder RE. Renal denervation in patients with chronic kidney disease: current evidence and future perspectives[J]. Nephrol Dial Transplant, 2023, 38(5): 1089-1096. DOI: 10.1093/ndt/gfac189.
|